300233.SZ Overview

Company Profile

Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin pharmaceutical intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. The company was founded in 2004 and is based in Zibo, China.

Related stocks

002165.SZ

002165.SZ • China

7.03 CNY

773.45M USD 1Y -19%

688707.SS

688707.SS • China

GUIZHOU ZHENHUA E-CHEM INC

11.16 CNY

849.55M USD 1Y -30.9%

300261.SZ

300261.SZ • China

4.9 CNY

706.3M USD 1Y -31.3%

000936.SZ

000936.SZ • China

5.61 CNY

743.76M USD 1Y -28%

900909.SS

900909.SS • China

SHANGHAI HUAYI GROUP CO LTD

0.5 USD

1.06B USD 1Y -12.4%

603113.SS

603113.SS • China

JINNENG SCIENCE AND TECHNOLOGY

5.09 CNY

646.24M USD 1Y -26.4%

603612.SS

603612.SS • China

SUNSTONE DEVELOPMENT CO LTD

16.32 CNY

1.22B USD 1Y -36.6%

300777.SZ

300777.SZ • China

19.69 CNY

1.3B USD 1Y -45.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

5 Metrics

Country

Region

Sector

Basic Materials

Industry

Website

https://www.jinchengpharm.com

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

49.3% p.a.

Max Drawdown (5Y)

-74.3%

Sharpe Ratio (5Y)

-0.33

Beta Factor

0.52

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

Strong cyclicality: The business model is sensitive to economic downturns.

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (49.3% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -74.8% in the extended horizon.